Insulin Glargine (U-100) Cartridge Systems and Pens and Renflexis Intravenous
Determining the interaction of Insulin Glargine (U-100) Cartridge Systems and Pens and Renflexis Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine
Brand name: Basaglar KwikPen, Lantus, Lantus Solostar Pen, Toujeo SoloStar, Lantus OptiClik Cartridge, Toujeo Max SoloStar, Lantus SoloStar
Synonyms: Insulin glargine, Insulin Glargine
Generic Name: infliximab
Brand name: Inflectra, Remicade, Renflexis
Synonyms: Renflexis
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin Glargine (U-100) Cartridge Systems and Pens-Reno Capsules
- Insulin Glargine (U-100) Cartridge Systems and Pens-Reno-30
- Insulin Glargine (U-100) Cartridge Systems and Pens-Reno-60
- Insulin Glargine (U-100) Cartridge Systems and Pens-Reno-Dip
- Insulin Glargine (U-100) Cartridge Systems and Pens-RenoCal-76
- Insulin Glargine (U-100) Cartridge Systems and Pens-Renografin-60
- Renflexis Intravenous-Insulin Glargine (U-100) Vials
- Renflexis Intravenous-Insulin Glargine (U-300) Pens
- Renflexis Intravenous-Insulin glargine and lixisenatide
- Renflexis Intravenous-Insulin glargine and lixisenatide Subcutaneous
- Renflexis Intravenous-Insulin glargine, recombinant Subcutaneous
- Renflexis Intravenous-Insulin glulisine